Clinical trial
Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
NCT01193127 is registered in ClinicalTrials.gov with Omeros Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
- Lead sponsor
- Omeros Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- February 28, 2011
- Enrollment
- 223 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.